Can primaquine therapy for vivax malaria be improved?

Trends in Parasitology

Volumn 19, Issue 3, 2003, Pages 115-120

  Baird, J Kevin ^b   Rieckmann, Karl H ^a  

^a AUSTRALIAN ARMY MALARIA INSTITUTE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; PRIMAQUINE; TAFENOQUINE;

BLOOD TOXICITY; CARDIOTOXICITY; CLINICAL PRACTICE; CLINICAL TRIAL; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; HUMAN; INFECTION PREVENTION; INTRAVASCULAR HEMOLYSIS; LIVER; LIVER TOXICITY; LONG TERM CARE; LOW DRUG DOSE; MALARIA; MALARIA CONTROL; METHEMOGLOBINEMIA; NEPHROTOXICITY; NONHUMAN; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RELAPSE; REVIEW; SCHIZONT; SHORT COURSE THERAPY; ZOONOSIS;

PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 0344837694     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4922(03)00005-9     Document Type: Review

References (60)

1. Mendis K., et al. The neglected burden of Plasmodium vivax malaria. Am. J. Trop. Med. Hyg. 64:(Suppl 1):2001;97-106.
2. Sharma V.P. Current scenario of malaria in India. Parassitologia. 41:1999;349-353.
3. Chai J.Y. Re-emerging Plasmodium vivax in the Republic of Korea. Korean J. Parasitol. 37:1999;129-143.
4. Roper M.H., et al. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Am. J. Trop. Med. Hyg. 62:2000;247-256.
5. Barcus M.J., et al. Epidemic malaria in the Menoreh Hills of Central Java. Am. J. Trop. Med. Hyg. 66:2002;2877-2892.
6. Sleigh A.C., et al. Resurgence of vivax malaria in Henan Province, China. Bull. WHO. 76:1998;265-270.
7. de Zulueta J. Changes in the geographical distribution of malaria throughout history. Parasitologia. 29:1987;1937-2005.
8. Garnham P.C. Hypnozoites and relapses in Plasmodium vivax and in vivax-like malaria. Trop. Geogr. Med. 40:1988;187-195.
9. Cogswell F.B. The hypnozoites and relapse in primate malaria. Clin. Microbiol. Rev. 5:1992;26-35.
10. Sweeney A.W. Wartime research on malaria chemotherapy. Parassitologia. 42:2000;337-345.
11. Greenwood D. Conflicts of interest: the genesis of synthetic antimalarial agents in peace and war. J. Antimicrob. Chemother. 36:1995;857-872.
12. Carson P.E. 8-Aminoquinolines. Peters W., Richards W.H.G. Antimalarial Drugs II. 1984;121-837 Springer-Verlag.
13. Pukrittayakamee S., et al. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J. Infect. Dis. 169:1994;932-935.
14. Baird J.K., et al. Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine. J. Infect. Dis. 171:1995;1678-1682.
15. Wilairatana P., et al. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax in Thailand. Am. J. Trop. Med. Hyg. 61:1999;973-977.
16. Arnold J., et al. The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria. J. Lab. Clin. Med. 46:1955;391-397.
17. Basco L.K., et al. In vitro activity of primaquine against the asexual blood stages of Plasmodium falciparum. Ann. Trop. Med. Parasitol. 93:1999;179-182.
18. Baird J.K., et al. Therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in Northeastern Papua, Indonesia. Am. J. Trop. Med. Hyg. 66:2002;6597-6660.
19. Brueckner R. 8-Aminoquinolines. Rosenthal P.J. Antimalarial Chemotherapy: Mechanisms of Action, Resistance and New Directions in Drug Discovery. 2001;151-1237 Humana Press.
20. Warhurst D.C. Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria? Ann. Trop. Med. Parasitol. 78:1984;165.
21. The Use of Antimalarial Drugs: Report of an Informal Consultation. 2001;. WHO/CDS/RBM/2001.33, Geneva. pp. 141.
22. Fryauff D.J., et al. Randomized, placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria in Indonesia. Lancet. 346:1995;1190-1193.
23. Weiss W.J., et al. Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: Comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J. Infect. Dis. 171:1995;1569-1575.
24. Soto J., et al. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. Ann. Intern. Med. 129:1998;241-244.
25. Schwartz E., Regev-Yochay G. Primaquine as prophylaxis for malaria in nonimmune travelers: a comparison with mefloquine and doxycycline. Clin. Infect. Dis. 29:1999;1502-1506.
26. Baird J.K., et al. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin. Infect. Dis. 33:2001;1907-1997.
27. Edgcomb J.H., et al. Primaquine, SN 13272, a new curative agent in vivax malaria: a preliminary report. J. Natl. Malaria Soc. 9:1950;285-292.
28. Alving A.S., et al. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am. J. Trop. Med. Hyg. 6:1953;970-976.
29. Coatney G.R., et al. Korean vivax malaria V. Cure of the infection by primaquine administered during long-term latency. Am. J. Trop. Med. Hyg. 6:1953;985-988.
30. Ehrman F.C., et al. Plasmodium vivax Chesson strain. Science. 101:1945;377.
31. Alving A.S., et al. Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull. WHO. 22:1960;621-631.
32. Alving A.S., et al. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J. Lab. Clin. Med. 46:1955;301-306.
33. Collins W.E., Jeffery G.M. PQ resistance in Plasmodium vivax. Am. J. Trop. Med. Hyg. 55:1996;243-249.
34. Bunnag D., et al. High dose primaquine in primaquine resistant vivax malaria. Trans. R. Soc. Trop. Med. Hyg. 88:1994;2187-2219.
35. Doherty J.F., et al. Treatment of Plasmodium vivax malaria - time for a change? Trans. R. Soc. Trop. Med. Hyg. 91:1997;76.
36. Luzzi G.A., et al. Treatment of primaquine-resistant Plasmodium vivax malaria. Lancet. 340:1992;310.
37. Clyde D.F., et al. Clinical problems associated with the use of primaquine as a tissue schizonticidal and gametocytocidal drug. Bull. WHO. 59:1981;391-395.
38. Martelo O.J., et al. Malaria in American soldiers. Arch. Intern. Med. 123:1969;383-387.
39. Fisher G.U., et al. Malaria in soldiers returning from Vietnam. Epidemiologic, therapeutic and clinical studies. Am. J. Trop. Med. Hyg. 19:1970;27-39.
40. Kaplan M.H., Bernstein L.S. Improved therapy for Vietnam acquired vivax malaria. Mil. Med. 6:1974;4447-4448.
41. Rowland M., Durrani N. Randomized controlled trials of 5 and 147 days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan. Trans. R. Soc. Trop. Med. Hyg. 93:1999;641-643.
42. Gogtay N.J., et al. Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections. Ann. Trop. Med. Parasitol. 93:1999;809-812.
43. Schmidt L.H., et al. Radical cure of infections with Plasmodium cynomolgi: A function of total 8-aminoquinoline dose. Am. J. Trop. Med. Hyg. 26:1977;1116-1128.
44. Clyde D.F., McCarthy V.E. Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine. Am. J. Trop. Med. Hyg. 26:1977;562-563.
45. Clayman C.B., et al. Toxicity of primaquine in Caucasians. J. Am. Med. Assoc. 149:1952;1563-1568.
46. Beutler E. G6PD deficiency. Blood. 84:1994;3613-3636.
47. Rieckmann K.H., et al. Plasmodium vivax resistant to chloroquine? Lancet ii. 1989;1183-1184.
48. Baird J.K., et al. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 44:1991;547-552.
49. Murphy G.S., et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 341:1993;96-100.
50. Than M., et al. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Trans. R. Soc. Trop. Med. Hyg. 89:1995;307-308.
51. Baird J.K., et al. In vivo resistance to chloroquine by Plasmodium vivax and Plasmodium falciparum at Nabire, Irian Jaya, Indonesia. Am. J. Trop. Med. Hyg. 56:1997;627-631.
52. Phillips E.J., et al. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax acquired in Guyana, South America. Clin. Infect. Dis. 23:1996;1171-1173.
53. Alecrim M.G., et al. Plasmodium vivax resistance to chloroquine and mefloquine in the Brazilian Amazon region. Rev. Soc. Bras. Med. Trop. 32:1999;67-68.
54. Wiselogle, F.Y. (1945) A Survey of Antimalarial Drugs: 1941-1945, 2 vols. J.W. Edwards.
55. Smoak B.L., et al. Plasmodium vivax infections in U.S. Army troops: Failure of primaquine to prevent relapse in studies from Somalia. Am. J. Trop. Med. Hyg. 56:1997;231-234.
56. Isaac-Renton J.L., et al. Drug resistance in malaria: three cases and a review. Can. Med. Assoc. J. 129:1983;454-457.
57. Henderson A., et al. Polyresistant malaria in Ghurka soldiers returning from Papua New Guinea: Treatment and prevention. J. R. Army Med. Corps. 132:1986;37-41.
58. Rombo L., et al. Seven patients with relapses of Plasmodium vivax or P. ovale despite primaquine treatment. Trop. Med. Parasitol. 38:1987;49-50.
59. Arias A.E., Corredor A. Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy. Trop. Geogr. Med. 40:1989;21-23.
60. Baird J.K., et al. Diagnosis of resistance to chloroquine by Plasmodium vivax: timing of recurrence and whole blood choroquine levels. Am. J. Trop. Med. Hyg. 56:1997;621-626.